medigraphic.com
ISSN 2007-8013 (Print)
Órgano oficial de la Universidad Autónoma de Sinaloa

2023, Number 3

<< Back Next >>

Rev Med UAS 2023; 13 (3)

Historical analysis of the prevalence of suspicious lesions of oral cancer in Mexico 2009- 2020

Cano-Verdugo G, de la Garza-Ramos MA

Language: Spanish
References: 24
Page: 278-287
PDF size: 344.40 Kb.


ABSTRACT

Objectives: To perform a historical analysis of the prevalence of suspected oral cancer lesions in Mexico 2009-2020 in order to discern their current implication in practice, population health and health policies. Material and method: We studied the information available from the Oral Disease and Pathology Surveillance System (SIVEPAB) and WHO, and proceeded to analyze and synthesize the data narratively. Chi-square was used to analyze the prevalence figures by year. Finally, the implication of the results obtained on population health, practice and health policies was analyzed. Results: The analysis showed a minimum of 103 and a maximum of 710 suspected oral cancer lesions in Mexico, with a mean of 419. In the statistical analysis, no significant differences were found between the reported number of lesions per year. Regarding its implications, it was found that knowledge of the existence of national reports is essential to make this growing pathology visible to population, and scientific community. Conclusions: Since these lesions are the precedent of oral cancer, which is associated with high mortality and lethality, it is important to analyze them in order to observe their behavior, their possible implication in practice, and the establishment of health policies that promote their registration and early detection.


REFERENCES

  1. Bugshan A, Farooq I. Oral squamous cellcarcinoma: metastasis, potentially associatedmalignant disorders, etiology and recentadvancements in diagnosis. F1000Research. 2020;9,229.

  2. Warnakulasuriya S, Kujan O, Aguirre?UrizarJM, Bagan JV, González?Moles M AR,Johnson NW. Oral potentially malignant disorders:A consensus report from an internationalseminar on nomenclature and classification,convened by the WHO CollaboratingCentre for Oral Cancer. Oral dis. 2021;27(8),1862-1880.

  3. Torres-Rosas R, Torres-Gómez N, Hernández-Juárez J, Pérez-Cervera Y, Hernández-Antonio A, Argueta-Figueroa L. Epidemiologíareportada de cáncer de labio, cavidadoral y orofaringe en México / Reported epidemiologyof cancer of the lip, oral cavity andoropharynx in Mexico. Rev Med Inst Mex.2021;58(4), 494-507. Recuperado dehttp://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/3621/4111

  4. Shu-Ching C. Oral dysfunction in patientswith head and neck cancer: a systematic review.J Nur Res. 2016;27(6), e58.

  5. Warnakulasuriya S, Kujan O, Aguirre-UrizarJM, Bagan JV, González-Moles MÁ, KerrAR, et al. Oral potentially malignant disorders:A consensus report from an internationalseminar on nomenclature and classification,convened by the WHO CollaboratingCentre for Oral Cancer. Oral Dis.2021;27(8):1862-1880.doi:10.1111/odi.13704.

  6. SIVEPAB. Resultados del Sistema de VigilanciaEpidemiológica de Patologías Bucales1st. Ed. México: Secretaría de Salud;2009-2020:pp65.

  7. Souza Filho BABD, Tritany ÉF, StruchinerCJ. Checklist for Theoretical Report in EpidemiologicalStudies (CRT-EE): explanationand elaboration. Physis: Rev Saud Col.2021;31, e310124.

  8. University of Northern Colorado. Thinkinglike a historian checklist. [INTERNET]. USA:Library of Congress; 2022. [consultadoagosto 2023]. Disponible en:https://studylib.net/doc/17755208/thinkinglike-a-historian-checklist--historical-thinking.

  9. Organización Mundial de la Salud. Cáncer.[INTERNET]. USA: OMS; 2022. [consultadoagosto 2023]. Disponible en:https://www.who.int/es/news-room/factsheets/detail/cancer 2022

  10. Orellana-Centeno JE, Morales-Castillo V.Sistema de Vigilancia epidemiológica de patologíasbucales a diez años de distancia.Rev Chil Sal P. 2019;23(1), 81-82.

  11. Organización Mundial de la Salud. Salud bucodental.[INTERNET]. USA: OMS; 2022.[consultado agosto 2023]. Recuperado de:https://www.who.int/es/news-room/factsheets/detail/oral-health

  12. Rivera-Burgos V, Galindez SB, Quintero YC,Narváez KO. Factores relacionados a la inasistenciaa un programa de hipertensión arterial.Rev Cien Soc. 2021;27(3), 139-150.

  13. Bravo YVN. Factores asociados a la inasistenciaal programa de enfermedades crónicasno transmisibles en el centro de salud deMuelle de los Bueyes [Tesis de doctorado].Managua: Universidad Nacional Autónomade Nicaragua; 2019. Recuperado a partir de:https://repositorio.unan.edu.ni/19084/.

  14. Arcentales Reina NM, Chachapoya AlbánEM. Factores que influyen en el Ausentismode las citas médicas en consulta externa delHospital General Docente de Calderón [Tesisde maestría]. Quito: Universidad Centralde Ecuador; 2019. Recuperado a partir de:http://www.dspace.uce.edu.ec/handle/25000/18328. .

  15. Chuang SL, Wang CP, Chen MK, Su WW,Su CW, Chen SL, et al. Malignant transformationto oral cancer by subtype of oral potentiallymalignant disorder: A prospectivecohort study of Taiwanese nationwide oralcancer screening program. Oral onc.2018;87, 58-63.

  16. Secretaría de Salud, Subsecretaría de Prevencióny Promoción de la Salud, DirecciónGeneral de Epidemiología. Perfil epidemiológicode los tumores malignos en México.México, D.F.:Secretaria de Salud;2011. Disponibleen:https://epidemiologiatlax.files.wordpress.com/2012/10/p_epi_de_los_tumores_malignos_mc3a9xico.pdf.

  17. Hernández-Guerrero JC, Jacinto-AlemánLF, Jiménez-Farfán MD, Macario-HernándezA, Hernández-Flores F, Alcántara-VázquezA. Prevalence trends of oral squamouscell carcinoma. Mexico City's General Hospitalexperience. Med Or pat. 2013;18(2),e306-e311.

  18. Muzio LL, Ballini A, Cantore S, Bottalico L,Charitos IA, Ambrosino M, et al. Overview ofCandida albicans and human papillomavirus(HPV) infection agents and their biomolecularmechanisms in promoting oral cancer inpediatric patients. BioMed Res Int. 2021;26(6): 1-8.

  19. American Cancer Society. (2023). Survivorship:During and After Treatment. Recuperadode: https://www.cancer.org/cancer/survivorship.html

  20. Mejía A, Rodríguez K, Lomelí G. Resultadosdel Sistema de Vigilancia Epidemiológica dePatologías bucales (SIVEPAB) en: DirecciónGeneral de Comunicación Social de la Secretaríade Salud. Secretaría de Salud.(Eds.) 1ª. Edición México, 2014, pp 1-72.

  21. de Abreu MHNG, Cruz AJS, Borges-OliveiraAC, Martins RC, Mattos FF. Perspectives onSocial and Environmental Determinants ofOral Health. Int J Env Pub H. 2021;18(24),13429.

  22. Fundytus K, Santamaria-Plaza C, McLarenL. Policy diffusion theory, evidence-informedpublic health, and public health politicalscience: a scoping review. Can Jour Pub H.2023;114(3), 331-345.

  23. Tranby EP, Heaton LJ, Tomar SL, Kelly AL,Fager GL, Backley M, Frantsve-Hawley J.Oral Cancer Prevalence, Mortality, andCosts in Medicaid and Commercial InsuranceClaims Data. Can Ep Biom & Prev:2021;31(9), 1849-1857.

  24. Singh AK, Chauhan R, Anand K, Singh M,Das SR, Sinha AK. Prevalence and RiskFactors for Oral Potentially Malignant Disordersin Indian Population. J Ph Bio Sc.2021;13(Suppl 1), S398-S401.




2020     |     www.medigraphic.com